Page last updated: 2024-08-26

nicotine and Tourette Syndrome

nicotine has been researched along with Tourette Syndrome in 30 studies

Research

Studies (30)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (13.33)	18.7374
1990's	15 (50.00)	18.2507
2000's	9 (30.00)	29.6817
2010's	2 (6.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sanberg, PR; Shytle, RD; Vindrola-Padros, C	1
Boye, SM	1
Schwartz, MA	1
Allen, TB; McEvoy, JP	1
Hayslett, RL; Tizabi, Y	2
Batth, S; Boisjoli, A; Howson, AL; Ilivitsky, V; Jaworski, M; Knott, VJ; Mahoney, C	1
Amann, B; Orth, M; Robertson, MM; Rothwell, JC	1
Bird, R; Dursun, SM; Reveley, MA; Stirton, F	1
Sanberg, PR; Silver, AA	1
Erdmann, R; Schneider, U	1
Philipp, MK; Sanberg, PR; Shytle, RD; Silver, AA	1
Erdmann, R	1
Dursun, SM; Reveley, MA	1
Cahill, DW; Fogelson, HM; McConville, BJ; Philipp, MK; Sanberg, PR; Shytle, RD; Silver, AA	1
Lindstrom, J	1
Mathé, JM; Nomikos, GG; Schilström, B; Svensson, TH	1
Dursun, SM; Kutcher, S	1
Darmani, NA; Johnson, M; Russell, LT; Tizabi, Y	1
McConville, B; Philipp, MK; Sanberg, PR; Shytle, RD; Silver, AA; Wilkinson, BJ	1
Singer, HS	1
Arevalo, E; Bronheim, S; Licamele, WL; Sonnenschein, K	1
Rickards, EH	1
Cirino, P; Fogelson, MH; King, J; McConville, BJ; Norman, AB; Parker, KW; Sanberg, PR	1
Fogelson, MH; Klykylo, WM; Manderscheid, PZ; McConville, BJ; Norman, AB; Parker, KW; Sanberg, PR	1
Emerich, DF; McConville, BJ; Norman, AB; Sanberg, PR; Zanol, MD	1
Manderscheid, PZ; Montgomery, SP; Moss, DE; Norman, AB; Sanberg, PR	1
Devor, EJ; Isenberg, KE	1
Blythe, MM; Fogelson, HM; Klykylo, WM; Manderscheid, PZ; McConville, BJ; Norman, AB; Parker, KW; Sanberg, PR	1
Fogelson, HM; Manderscheid, PZ; McConville, BJ; Norman, AB; Parker, KW; Sanberg, PR	1

Reviews

8 review(s) available for nicotine and Tourette Syndrome

Article	Year
Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond. Physiology & behavior, 2012, Dec-05, Volume: 107, Issue:5 Topics: Animals; Basal Ganglia; Depression; Humans; Mecamylamine; Nicotine; Tourette Syndrome; Translational Research, Biomedical	2012
The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome. Current drug targets. CNS and neurological disorders, 2002, Volume: 1, Issue:4 Topics: Bipolar Disorder; Cholinergic Agents; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Schizophrenia; Smoking; Tourette Syndrome	2002
[Nicotine in neuropsychiatric movement disorders]. Fortschritte der Neurologie-Psychiatrie, 1996, Volume: 64, Issue:9 Topics: Adult; Akathisia, Drug-Induced; Brain; Child; Dyskinesia, Drug-Induced; Haloperidol; Humans; Nicotine; Parkinson Disease; Receptors, Dopamine; Tourette Syndrome	1996
Nicotine for the treatment of Tourette's syndrome. Pharmacology & therapeutics, 1997, Volume: 74, Issue:1 Topics: Adolescent; Adult; Animals; Antipsychotic Agents; Child; Female; Ganglionic Stimulants; Humans; Male; Nicotiana; Nicotine; Phytotherapy; Plants, Toxic; Rats; Tourette Syndrome	1997
Nicotinic acetylcholine receptors in health and disease. Molecular neurobiology, 1997, Volume: 15, Issue:2 Topics: Acetylcholine; Alzheimer Disease; Anesthetics; Animals; Autoimmune Diseases; Cholinergic Agents; Cholinergic Antagonists; Epilepsy; Ethanol; Female; Keratinocytes; Male; Models, Molecular; Muscle Proteins; Myasthenia Gravis; Nerve Tissue Proteins; Neuromuscular Junction; Nicotine; Parkinson Disease; Pregnancy; Protein Conformation; Receptors, Nicotinic; Schizophrenia; Smoking; Torpedo; Tourette Syndrome	1997
Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research. Medical hypotheses, 1999, Volume: 52, Issue:2 Topics: Acetylcholine; Anxiety Disorders; Dopamine; Ethics, Medical; Humans; Mental Disorders; Models, Neurological; Mood Disorders; Nicotine; Norepinephrine; Psychopharmacology; Receptors, Nicotinic; Schizophrenia; Serotonin; Smoking; Tourette Syndrome	1999
The treatment of tics. Current neurology and neuroscience reports, 2001, Volume: 1, Issue:2 Topics: Adrenergic alpha-Agonists; Androgen Antagonists; Anti-Bacterial Agents; Antipsychotic Agents; Autoimmune Diseases; Botulinum Toxins, Type A; Cannabinoids; Clinical Trials as Topic; Cross-Over Studies; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Gonadal Steroid Hormones; Humans; Immunoglobulins, Intravenous; Neurosurgical Procedures; Nicotine; Randomized Controlled Trials as Topic; Receptors, Dopamine; Receptors, Nicotinic; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Streptococcal Infections; Tics; Tourette Syndrome	2001
Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders. Life sciences, 1989, Volume: 44, Issue:21 Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Cannabinoids; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Tourette Syndrome	1989

Trials

5 trial(s) available for nicotine and Tourette Syndrome

Article	Year
Clinical and attentional effects of acute nicotine treatment in Tourette's syndrome. European psychiatry : the journal of the Association of European Psychiatrists, 2004, Volume: 19, Issue:2 Topics: Administration, Cutaneous; Adolescent; Analysis of Variance; Antipsychotic Agents; Attention; Child; Double-Blind Method; Electroencephalography; Evoked Potentials; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Reaction Time; Severity of Illness Index; Task Performance and Analysis; Time Factors; Tourette Syndrome; Treatment Outcome; Videotape Recording	2004
Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine. Brain : a journal of neurology, 2005, Volume: 128, Issue:Pt 6 Topics: Adult; Electromyography; Evoked Potentials, Motor; Female; Humans; Magnetics; Male; Middle Aged; Motor Cortex; Neural Inhibition; Neurons, Afferent; Nicotine; Nicotinic Agonists; Severity of Illness Index; Tics; Tourette Syndrome	2005
Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 1996, Volume: 35, Issue:12 Topics: Administration, Cutaneous; Adolescent; Antipsychotic Agents; Child; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Tourette Syndrome	1996
Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:9 Topics: Administration, Cutaneous; Antipsychotic Agents; Cotinine; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Haloperidol; Humans; Nicotine; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Tourette Syndrome; Treatment Outcome	2001
The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder. Biological psychiatry, 1992, Apr-15, Volume: 31, Issue:8 Topics: Adolescent; Adult; Chewing Gum; Child; Drug Synergism; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Nicotine; Placebos; Polymethacrylic Acids; Polyvinyls; Psychiatric Status Rating Scales; Severity of Illness Index; Tobacco Use Cessation Devices; Tourette Syndrome; Videotape Recording	1992

Other Studies

17 other study(ies) available for nicotine and Tourette Syndrome

Article	Year
Individual phenotype predicts nicotine-haloperidol interaction in catalepsy: possible implication for the therapeutic efficacy of nicotine in Tourette's syndrome. Behavioural brain research, 2013, Jan-01, Volume: 236, Issue:1 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Drug Synergism; Environment; Haloperidol; Individuality; Male; Motor Activity; Nicotine; Nicotinic Agonists; Phenotype; Rats; Rats, Sprague-Dawley; Tourette Syndrome	2013
Nicotine-induced angiogenesis. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:10 Topics: Administration, Cutaneous; Humans; Neovascularization, Pathologic; Nicotine; Receptors, Nicotinic; Tourette Syndrome	2002
Effects of donepezil on DOI-induced head twitch response in mice: implications for Tourette syndrome. Pharmacology, biochemistry, and behavior, 2003, Volume: 76, Issue:3-4 Topics: Amphetamines; Animals; Donepezil; Drug Synergism; Head Movements; Indans; Male; Mecamylamine; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Piperidines; Serotonin Receptor Agonists; Tics; Time Factors; Tourette Syndrome	2003
Effects of donepezil, nicotine and haloperidol on the central serotonergic system in mice: implications for Tourette's syndrome. Pharmacology, biochemistry, and behavior, 2005, Volume: 81, Issue:4 Topics: Amphetamines; Animals; Behavior, Animal; Binding, Competitive; Cerebral Cortex; Corpus Striatum; Donepezil; Dose-Response Relationship, Drug; Frontal Lobe; Gene Expression; Haloperidol; Humans; Indans; Ketanserin; Male; Mesencephalon; Mice; Mice, Inbred ICR; Nicotine; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serotonin Antagonists; Tourette Syndrome	2005
Longlasting improvement of Tourette's syndrome with transdermal nicotine. Lancet (London, England), 1994, Dec-03, Volume: 344, Issue:8936 Topics: Administration, Cutaneous; Adolescent; Adult; Humans; Male; Middle Aged; Nicotine; Severity of Illness Index; Tourette Syndrome	1994
Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome. Lancet (London, England), 1993, Jul-17, Volume: 342, Issue:8864 Topics: Administration, Cutaneous; Adolescent; Child; Drug Synergism; Female; Haloperidol; Humans; Male; Middle Aged; Nicotine; Smoking; Tourette Syndrome	1993
[Nicotine and Tourette's syndrome]. Psychiatrische Praxis, 1996, Volume: 23, Issue:1 Topics: Administration, Cutaneous; Adolescent; Antipsychotic Agents; Drug Therapy, Combination; Humans; Male; Neurologic Examination; Nicotine; Tourette Syndrome; Treatment Outcome	1996
Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study. Psychological medicine, 1997, Volume: 27, Issue:2 Topics: Administration, Cutaneous; Adolescent; Adult; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Nicotine; Receptors, Nicotinic; Tourette Syndrome; Treatment Failure	1997
Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine. Amino acids, 1998, Volume: 14, Issue:1-3 Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Male; Nicotine; Parkinson Disease; Rats; Receptors, N-Methyl-D-Aspartate; Tourette Syndrome; Ventral Tegmental Area	1998
Nicotine attenuates DOI-induced head-twitch response in mice: implications for Tourette syndrome. Progress in neuro-psychopharmacology & biological psychiatry, 2001, Volume: 25, Issue:7 Topics: Animals; Brain; Drug Administration Schedule; Head Movements; Indophenol; Male; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Serotonin Receptor Agonists; Tics; Tourette Syndrome	2001
Nicotine gum in Tourette's disorder. The American journal of psychiatry, 1992, Volume: 149, Issue:3 Topics: Chewing Gum; Drug Synergism; Drug Therapy, Combination; Haloperidol; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Research Design; Tobacco Use Cessation Devices; Tourette Syndrome	1992
Nicotine gum in Tourette's disorder. The American journal of psychiatry, 1992, Volume: 149, Issue:3 Topics: Chewing Gum; Drug Therapy, Combination; Haloperidol; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Tobacco Use Cessation Devices; Tourette Syndrome	1992
Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder. The American journal of psychiatry, 1991, Volume: 148, Issue:6 Topics: Adolescent; Adult; Chewing Gum; Child; Drug Synergism; Female; Haloperidol; Humans; Male; Middle Aged; Nicotine; Tourette Syndrome	1991
Nicotine potentiates haloperidol-induced catalepsy and locomotor hypoactivity. Pharmacology, biochemistry, and behavior, 1991, Volume: 38, Issue:4 Topics: Animals; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Haloperidol; Humans; Male; Motor Activity; Nicotine; Rats; Rats, Inbred Strains; Tourette Syndrome	1991
Nicotine and Tourette's syndrome. Lancet (London, England), 1989, Oct-28, Volume: 2, Issue:8670 Topics: Adult; Humans; Male; Nicotine; Smoking; Tourette Syndrome	1989
Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1989, Volume: 43, Issue:1 Topics: Adolescent; Animals; Behavior, Animal; Catalepsy; Chewing Gum; Child; Child, Preschool; Drug Interactions; Female; Haloperidol; Humans; Male; Nicotine; Rats; Rats, Inbred Strains; Tic Disorders; Tourette Syndrome	1989
Nicotine gum and haloperidol in Tourette's syndrome. Lancet (London, England), 1988, Mar-12, Volume: 1, Issue:8585 Topics: Chewing Gum; Child; Haloperidol; Humans; Male; Nicotine; Polymethacrylic Acids; Polyvinyls; Tobacco Use Cessation Devices; Tourette Syndrome	1988